Protective effects of Lacticaseibacillus rhamnosus Hao9 on dextran sulphate sodium-induced ulcerative colitis in mice.
Lacticaseibacillus rhamnosus Hao9
curcumin
gut microbiota
inflammatory bowel disease
ulcerative colitis
Journal
Journal of applied microbiology
ISSN: 1365-2672
Titre abrégé: J Appl Microbiol
Pays: England
ID NLM: 9706280
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
revised:
09
05
2022
received:
25
03
2022
accepted:
09
06
2022
pubmed:
16
6
2022
medline:
8
9
2022
entrez:
15
6
2022
Statut:
ppublish
Résumé
Some probiotics used as food additives or food supplements had an anti-inflammatory effect. We tested the potential protective effects of probiotic Lacticaseibacillus rhamnosus Hao9 (Hao9) in mice with dextran sulphate sodium (DSS)-induced ulcerative colitis (UC) and determined whether these effects were related to the modulation of gut microbiota and amelioration of inflammation. Ulcerative colitis mouse model was established by feeding mice with 2.5% (w/v) DSS in drinking water for 7 days. We analysed the disease activity index (DAI), colon length and histological changes in the colon. In addition, we investigated the effects of Hao9 (1 × 10 Hao9 had a protective effect against DSS-induced colitis, and the mechanisms underlying Hao9 may involve controlling inflammation and maintaining host micro-ecological balance. This study provided experimental evidence for the application of Hao9 in the treatment of ulcerative colitis and suggested that Hao9 may be a promising candidate as a dietary supplement against colitis. The comparison of probiotics and prebiotics in terms of therapeutic efficacy in UC helps us to understand their different patterns of regulation of intestinal microbiota.
Substances chimiques
Anti-Inflammatory Agents
0
Cytokines
0
Interleukin-6
0
Dextran Sulfate
9042-14-2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2039-2049Subventions
Organisme : National Natural Science Foundation of China
ID : 32102007
Informations de copyright
© 2022 The Society for Applied Microbiology.
Références
Anand, P., Thomas, S.G., Kunnumakkara, A.B., Sundaram, C., Harikumar, K.B., Sung, B. et al. (2008) Biological activities of curcumin and its analogues (Congeners) made by man and mother nature. Biochemical Pharmacology, 76, 1590-1611. https://doi.org/10.1016/j.bcp.2008.08.008
Atarashi, K., Tanoue, T., Oshima, K., Suda, W., Nagano, Y., Nishikawa, H. et al. (2013) Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature, 500, 232-236. https://doi.org/10.1038/nature12331
Catarino, M.D., Marçal, C., Bonifácio-Lopes, T., Campos, D., Mateus, N., Silva, A. et al. (2021) Impact of phlorotannin extracts from fucus vesiculosus on human gut microbiota. Marine Drugs, 19, 375. https://doi.org/10.3390/md19070375
Cotillard, A., Kennedy, S.P., Kong, L.C., Prifti, E., Pons, N., Le Chatelier, E. et al. (2013) Dietary intervention impact on gut microbial gene richness. Nature, 500, 585-588. https://doi.org/10.1038/nature12480
Edgar, R.C. (2016) SINTAX: a simple non-Bayesian taxonomy classifier for 16S and ITS sequences. bioRxiv, 074161. https://doi.org/10.1101/074161
Eisenstein, M. (2018) Ulcerative colitis: towards remission. Nature, 563, S33. https://doi.org/10.1038/d41586-018-07276-2
FAO/WHO. (2001) Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Available at: http://www.fao.org/3/a-a0512e.pdf [Accessed 1-4 October 2001].
Feng, W., Wang, H., Zhang, P., Gao, C., Tao, J., Ge, Z. et al. (2017) Modulation of gut microbiota contributes to curcumin-mediated attenuation of hepatic steatosis in rats. Biochimica et Biophysica Acta-General Subjects, 1861, 1801-1812. https://doi.org/10.1016/j.bbagen.2017.03.017
Ford, A.C., Quigley, E.M., Lacy, B.E., Lembo, A.J., Saito, Y.A., Schiller, L.R. et al. (2014) Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. The American Journal of Gastroenterology, 109, 1547-1561. https://doi.org/10.1038/ajg.2014.202
Ganji-Arjenaki, M. & Rafieian-Kopaei, M. (2018) Probiotics are a good choice in remission of inflammatory bowel diseases: a meta-analysis and systematic review. Journal of Cellular Physiology, 233, 2091-2103. https://doi.org/10.1002/jcp.25911
Gerritsen, J. (2015) The genus Romboutsia: genomic and functional characterization of novel bacteria dedicated to life in the intestinal tract. Wageningen, the Netherlands: Wageningen University.
Gerritsen, J., Hornung, B., Ritari, J., Paulin, L., Rijkers, G.T., Schaap, P.J. et al. (2019) A comparative and functional genomics analysis of the genus Romboutsia provides insight into adaptation to an intestinal lifestyle. bioRxiv, 845511. https://doi.org/10.1101/845511
Ghosh, S.S., Bie, J., Wang, J. & Ghosh, S. (2014) Oral supplementation with non-absorbable antibiotics or curcumin attenuates western diet-induced atherosclerosis and glucose intolerance in LDLR-mice-role of intestinal permeability and macrophage activation. PLoS One, 9, e108577. https://doi.org/10.1371/journal.pone.0108577
Gibson, G.R., Hutkins, R., Sanders, M.E., Prescott, S.L., Reimer, R.A., Salminen, S.J. et al. (2017) Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nature Reviews Gastroenterology & Hepatology, 14, 491-502. Available from: 10.1038/nrgastro.2017.75
Glymenaki, M., Singh, G., Brass, A., Warhurst, G., McBain, A.J., Else, K.J. et al. (2017) Compositional changes in the gut mucus microbiota precede the onset of colitis-induced inflammation. Inflammatory Bowel Diseases, 23, 912-922. https://doi.org/10.1097/MIB.0000000000001118
Gondal, B., Haider, H., Komaki, Y., Komaki, F., Micic, D., Rubin, D.T. et al. (2020) Efficacy of various endoscopic modalities in detecting dysplasia in ulcerative colitis: a systematic review and network meta-analysis. World Journal of Gastrointestinal Endoscopy, 12, 159, 171. https://doi.org/10.4253/wjge.v12.i5.159
Hassan, S.M. & Hassan, A.H. (2018) The possibility of using shogaol for treatment of ulcerative colitis. Iranian Journal of Basic Medical Sciences, 21, 943. https://doi.org/10.22038/ijbms.2018.28616.6932, 949
Iida, T., Onodera, K. & Nakase, H. (2017) Role of autophagy in the pathogenesis of inflammatory bowel disease. World Journal of Gastroenterology, 23, 1944. https://doi.org/10.3748/wjg.v23.i11.1944, 1953
Kaplan, G.G. (2015) The global burden of IBD: from 2015 to 2025. Nature Reviews Gastroenterology & Hepatology, 12, 720-727. https://doi.org/10.1038/nrgastro.2015.150
Kaser, A. & Blumberg, R.S. (2011) Autophagy, microbial sensing, endoplasmic reticulum stress, and epithelial function in inflammatory bowel disease. Gastroenterology, 140, 1738-1747. https://doi.org/10.1053/j.gastro.2011.02.048
Khor, B., Gardet, A. & Xavier, R.J. (2011) Genetics and pathogenesis of inflammatory bowel disease. Nature, 474, 307-317. https://doi.org/10.1038/nature10209
Kolde, R. (2012) Pheatmap: pretty heatmaps. R Package Version. 1, 726.
Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G. et al. (2013) Richness of human gut microbiome correlates with metabolic markers. Nature, 500, 541-546. https://doi.org/10.1038/nature12506
Lee, C.S. & Kim, S.H. (2020) Anti-inflammatory and anti-osteoporotic potential of Lactobacillus plantarum A41 and L. fermentum SRK414 as probiotics. Probiotics and Antimicrobial Proteins, 12, 623-634. https://doi.org/10.1007/s12602-019-09577-y
Lin, Y., Zheng, X., Chen, J., Luo, D., Xie, J., Su, Z. et al. (2020) Protective effect of Bruguiera gymnorrhiza (L.) Lam. fruit on dextran sulfate sodium-induced ulcerative colitis in mice: role of Keap1/Nrf2 pathway and gut microbiota. Frontiers in Pharmacology, 10. https://doi.org/10.3389/fphar.2019.01602
MacDonald, T.T., Biancheri, P., Sarra, M. & Monteleone, G. (2012) What's the next best cytokine target in IBD. Inflammatory Bowel Diseases, 18, 2180-2189. https://doi.org/10.1002/ibd.22967
Mangifesta, M., Mancabelli, L., Milani, C., Gaiani, F., de'Angelis, N., de'Angelis, G.L. et al. (2018) Mucosal microbiota of intestinal polyps reveals putative biomarkers of colorectal cancer. Scientific Reports, 8, 13974. https://doi.org/10.1038/s41598-018-32413-2
McFadden, R.M.T., Larmonier, C.B., Shehab, K.W., Midura-Kiela, M., Ramalingam, R., Harrison, C.A. et al. (2015) The role of curcumin in modulating colonic microbiota during colitis and colon cancer prevention. Inflammatory Bowel Diseases, 21, 2483-2494. https://doi.org/10.1016/S0016-5085(14)60234-1
Meng, D., Liang, L. & Guo, X. (2019) Serum interleukin-10 level in patients with inflammatory bowel disease: a meta-analysis. European Journal of Inflammation, 17, 1-7. https://doi.org/10.1177/2058739219843405
Neuman, M.G. (2007) Immune dysfunction in inflammatory bowel disease. Translational Research, 149, 173-186. https://doi.org/10.1111/j.1365-2796.2012.02515.x
Neumann, H., Vieth, M., Langner, C., Neurath, M.F. & Mudter, J. (2011) Cancer risk in IBD: how to diagnose and how to manage DALM and ALM. World Journal of Gastroenterology, 17, 3184-3191. https://doi.org/10.3748/wjg.v17.i27.3184
Ng, S.C., Shi, H.Y., Hamidi, N., Underwood, F.E., Tang, W., Benchimol, E.I. et al. (2017) The worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Gastroenterology, 152, s970-s971. https://doi.org/10.1016/S0016-5085(17)33292-4
Nostrant, T.T., Kumar, N.B. & Appelman, H.D. (1987) Histopathology differentiates acute self-limited colitis from ulcerative colitis. Gastroenterology, 92, 318-328. https://doi.org/10.1016/0016-5085(87)90124-7
Oksanen, J., Blanchet, F., Friendly, M., Kindt, R., Legendre, P., McGlinn, D. et al. (2019) Vegan: community ecology package. R Package Version 2.5-6.
Panaccione, R., Rutgeerts, P., Sandborn, W.J., Schreiber, S., Colombel, J.F. & Berg, S. (2017) Adalimumab efficacy and safety by disease duration: analysis of pooled studies of Crohn's disease. Gastroenterology, 152, s744. https://doi.org/10.1016/S0016-5085(17)32584-2
Russo, L., Schneider, G., Gardiner, M.H., Lanes, S., Streck, P. & Rosen, S. (2014) Role of pharmacoepidemiology studies in addressing pharmacovigilance questions: a case example of pancreatitis risk among ulcerative colitis patients using mesalazine. European Journal of Clinical Pharmacology, 70, 709-717. https://doi.org/10.1007/s00228-014-1660-7
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W.S. et al. (2011) Metagenomic biomarker discovery and explanation. Genome Biology, 12, R60. https://doi.org/10.1186/gb-2011-12-6-r60
Sharma, R., Gescher, A. & Steward, W. (2005) Curcumin: the story so far. European Journal of Cancer, 41, 1955-1968. https://doi.org/10.1016/j.ejca.2005.05.009
Shen, J., Zuo, Z.X. & Mao, A.P. (2014) Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn's disease, and pouchitis: meta-analysis of randomized controlled trials. Inflammatory Bowel Diseases, 20, 21-35. https://doi.org/10.1097/01.MIB.0000437495.30052.be
Shen, L. & Ji, H.F. (2016) Intestinal microbiota and metabolic diseases: pharmacological implications. Trends in Pharmacological Sciences, 37, 169-171. https://doi.org/10.1016/j.tips.2015.11.010
Shen, L., Liu, L. & Ji, H.F. (2017) Regulative effects of curcumin spice administration on gut microbiota and its pharmacological implications. Food & Nutrition Research, 61, 1361780. https://doi.org/10.1080/16546628.2017.1361780
Siciliano, R.A., Lippolis, R. & Mazzeo, M.F. (2019) Proteomics for the investigation of surface-exposed proteins in probiotics. Frontiers in Nutrition, 6, 52. https://doi.org/10.3389/fnut.2019.00052
Sobhani, I., Tap, J., Roudot-Thoraval, F., Roperch, J.P., Letulle, S., Langella, P. et al. (2011) Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One, 6, e16393. https://doi.org/10.1371/journal.pone.0016393
Wallace, K.L., Zheng, L.B., Kanazawa, Y. & Shih, D.Q. (2014) Immunopathology of inflammatory bowel disease. World Journal of Gastroenterology, 20, 6-21. https://doi.org/10.3748/wjg.v20.i1.6
Wu, X., Wang, L., Tang, L., Wang, L., Cao, S., Wu, Q. et al. (2018) Salvianolic acid B alters the gut microbiota and mitigates colitis severity and associated inflammation. Journal of Functional Foods, 46, 312-319. https://doi.org/10.1016/j.jff.2018.04.068
Zagato, E., Pozzi, C., Bertocchi, A., Schioppa, T., Saccheri, F., Guglietta, S. et al. (2020) Endogenous murine microbiota member Faecalibaculum rodentium and its human homologue protect from intestinal tumour growth. Nature Microbiology, 5, 511-524. https://doi.org/10.1038/s41564-019-0649-5
Zam, W. (2018) Gut microbiota as a prospective therapeutic target for curcumin: a review of mutual influence. Journal of Nutrition and Metabolism, 12, 1367984. https://doi.org/10.1155/2018/1367984
Zhang, X.J., Yuan, Z.W., Qu, C., Yu, X.T., Huang, T., Chen, P.V. et al. (2018) Palmatine ameliorated murine colitis by suppressing tryptophan metabolism and regulating gut microbiota. Pharmacological Research, 137, 34-46. https://doi.org/10.1016/j.phrs.2018.09.010